We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$18.5B
AUM Growth
+$1.17B
Cap. Flow
+$442M
Cap. Flow %
2.39%
Top 10 Hldgs %
50.51%
Holding
28
New
Increased
22
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$248M
2
GWW icon
W.W. Grainger
GWW
+$210M
3
PFE icon
Pfizer
PFE
+$200M
4
WFC icon
Wells Fargo
WFC
+$191M
5
HCA icon
HCA Healthcare
HCA
+$165M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$637M
2
PGR icon
Progressive
PGR
+$629M
3
AVT icon
Avnet
AVT
+$161M
4
MD icon
Pediatrix Medical
MD
+$120M
5
TEL icon
TE Connectivity
TEL
+$63.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.21%
2 Financials 26.3%
3 Industrials 17.04%
4 Technology 14.8%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
1
Aon
AON
$80.4B
$1.02B 5.53%
7,001,377
+301,300
+4% +$42M
APTV icon
2
Aptiv
APTV
$12.3B
$1B 5.43%
10,211,866
+439,200
+4% +$41.4M
PH icon
3
Parker-Hannifin
PH
$119B
$947M 5.12%
5,413,458
+278,500
+5% +$45.7M
FIS icon
4
Fidelity National Information Services
FIS
$23.9B
$936M 5.06%
10,025,942
+521,300
+5% +$47.4M
UNH icon
5
UnitedHealth
UNH
$385B
$925M 5%
4,724,845
+214,300
+5% +$41.4M
BNY
6
Bank of New York Mellon
BNY
$104B
$922M 4.98%
17,381,984
+862,800
+5% +$45.3M
DG icon
7
Dollar General
DG
$28.3B
$918M 4.96%
11,321,660
+3,310,168
+41% +$248M
GWW icon
8
W.W. Grainger
GWW
$64.4B
$899M 4.86%
5,001,477
+1,245,771
+33% +$210M
WFC icon
9
Wells Fargo
WFC
$257B
$890M 4.81%
16,146,737
+3,602,070
+29% +$191M
HCA icon
10
HCA Healthcare
HCA
$91.8B
$886M 4.79%
11,135,155
+2,053,701
+23% +$165M
ZBH icon
11
Zimmer Biomet
ZBH
$18.7B
$879M 4.75%
7,731,885
+1,162,843
+18% +$134M
IQV icon
12
IQVIA
IQV
$40.4B
$876M 4.73%
9,218,227
+506,780
+6% +$47M
WTW icon
13
Willis Towers Watson
WTW
$30.1B
$876M 4.73%
5,677,694
+355,228
+7% +$53M
ORCL icon
14
Oracle
ORCL
$339B
$872M 4.71%
18,030,571
+1,783,200
+11% +$88.7M
PFE icon
15
Pfizer
PFE
$144B
$870M 4.7%
25,685,634
+6,219,759
+32% +$200M
EMR icon
16
Emerson Electric
EMR
$81.8B
$865M 4.67%
13,758,325
+1,134,275
+9% +$68.4M
TMO icon
17
Thermo Fisher Scientific
TMO
$213B
$864M 4.67%
4,564,913
+313,782
+7% +$56.8M
STT icon
18
State Street
STT
$48.9B
$770M 4.16%
8,062,726
+493,244
+7% +$45.9M
FISV
19
Fiserv Inc
FISV
$29.7B
$695M 3.76%
10,783,038
+2,040,242
+23% +$127M
TMX
20
DELISTED
Terminix Global Holdings, Inc.
TMX
$444M 2.4%
14,170,035
+623,749
+5% +$18.4M
OMC icon
21
Omnicom Group
OMC
$23.7B
$419M 2.26%
5,653,698
+1,653,208
+41% +$127M
PGR icon
22
Progressive
PGR
$129B
$296M 1.6%
6,106,851
-13,440,167
-69% -$629M
ARW icon
23
Arrow Electronics
ARW
$10.4B
$236M 1.28%
2,936,104
+143,540
+5% +$11.3M
MD icon
24
Pediatrix Medical
MD
$2.17B
$107M 0.58%
2,491,731
-2,531,745
-50% -$120M
AXP icon
25
American Express
AXP
$225B
$93.1M 0.5%
1,028,945
-41,170
-4% -$3.54M

Similar funds

Longview Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Longview Partners held 28 positions worth $18.5B, up 6.8% from $17.3B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Longview Partners's Q3 2017 filing shows 22 increased, 3 reduced and 3 closed positions. The largest sale was Accenture, an estimated $637M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Industrials.

  • Longview Partners added most to Dollar General in Q3 2017, an estimated $248M increase.
  • Longview Partners's biggest Q3 2017 reduction was Progressive, cutting an estimated $629M.
  • Longview Partners fully exited Accenture in Q3 2017, selling an estimated $637M.
  • Longview Partners's ten largest holdings make up 51% of its $18.5B portfolio in Q3 2017.
  • Longview Partners opened 0 new positions and closed 3 in Q3 2017.
  • Longview Partners's portfolio value rose 6.8% quarter-over-quarter to $18.5B.

Based on Longview Partners's 13F filing for Q3 2017, filed 30 Oct 2017.